Am Heart J

1. KITTIPIBUL V, Yaranov DM, Biegus J, Gray JM, et al
   Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure.
   Am Heart J. 2024;271:178-181.
   

   >> Share

   
   
2. RAO VN, Sharma A, Stebbins A, Buse JB, et al
   Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes.
   Am Heart J. 2024 Feb 21:S0002-8703(24)00040-1. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   

   
   Am J Cardiol

3. GUPTA R, Bermudez F, Vora T, Homayouni N, et al
   Surveillance Imaging and Management of Cardiac Sarcoidosis after Advanced Heart Failure Therapies.
   Am J Cardiol. 2024 Apr 23:S0002-9149(24)00311.
   

   >> Share

   
   

   
   Cardiovasc Res

4. KAHNERT K, Soattin L, Mills RW, Wilson C, et al
   Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction.
   Cardiovasc Res. 2024 Apr 25:cvae054. doi: 10.1093.
   

   >> Share

   
   

   
   Circulation

5. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
   Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
   Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
   

   >> Share

   
   

   
   Eur Heart J

6. JACKSON AM, Goland S, Farhan HA, Yaseen IF, et al
   A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
   Eur Heart J. 2024;45:1430-1439.
   

   >> Share

   
   

   
   Eur J Heart Fail

7. ANKER SD, Friede T, von Bardeleben RS, Butler J, et al
   Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial design.
   Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3247.
   

   >> Share

   
   
8. LIEN T, Srikanth K, Ambrosy AP
   Follow the EMPULSE: In-hospital initiation of empagliflozin for heart failure across the spectrum of left ventricular ejection fraction.
   Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3256.
   

   >> Share

   
   
9. PAGNESI M, Adamo M, Metra M
   Is it NICE to measure natriuretic peptides after a hospitalization for heart failure?
   Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3257.
   

   >> Share

   
   
10. GRASSI G, Dell'Oro R, Quarti-Trevano F
    Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes.
    Eur J Heart Fail. 2024 Apr 25. doi: 10.1002/ejhf.3258.
    

    >> Share

    
    
11. GORTER TM, Hoendermis ES, van Veldhuisen DJ
    Interatrial shunting as a treatment for heart failure: Where do we stand?
    Eur J Heart Fail. 2024 Apr 25. doi: 10.1002/ejhf.3251.
    

    >> Share

    
    

    
    Heart

12. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    

    >> Share

    
    

    
    Int J Cardiol

13. HONG Y, Gao Z, Wei H, Wei Y, et al
    Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
    Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
    

    >> Share

    
    
14. PEZZUTO B, Contini M, Berna G, Galotta A, et al
    Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
    Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
    

    >> Share

    
    
15. CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
    Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
    Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
    

    >> Share

    
    
16. TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
    Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

17. CHOKSEY A, Carter RD, Thackray BD, Ball V, et al
    AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
    J Mol Cell Cardiol. 2024;191:12-22.
    

    >> Share

    
    

    
    N Engl J Med

18. BUTLER J, Jones WS, Udell JA, Anker SD, et al
    Empagliflozin after Acute Myocardial Infarction.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2314051.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share